Filter
427
Text search:
immunocompromised
Featured
Recommendations
54
New Publications
73
Language
Document type
No document type
169
Guidelines
144
Studies & Reports
43
Fact sheets
23
Manuals
22
Strategic & Response Plan
11
Training Material
7
Situation Updates
3
Infographics
3
Brochures
1
Resource Platforms
1
Countries / Regions
India
26
Western and Central Europe
16
Latin America and the Carribbean
13
South Africa
11
Global
9
Africa
8
Kenya
7
Philippines
5
Syria
5
Middle East and North Africa
5
Nigeria
4
Mozambique
4
Ukraine
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Germany
3
Tanzania
3
Rwanda
3
Malawi
3
Brazil
3
East and Southern Africa
3
South–East Asia Region
3
Venezuela
3
Eastern Europe
3
Russia
3
Congo, Democratic Republic of
2
Mali
2
USA
2
Ethiopia
2
Niger
2
Nepal
2
Zambia
2
Indonesia
2
Argentina
2
Myanmar / Burma
2
Chile
2
Yemen
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Mauritania
1
Bangladesh
1
Singapore
1
Sudan
1
Benin
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Western Pacific Region
1
Asia
1
Albania
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Georgia
1
North America
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
115
Clinical Guidelines
77
Public Health
12
Women & Child Health
12
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
1
Toolboxes
COVID-19
115
TB
59
HIV
31
Rapid Response
23
AMR
22
NTDs
15
Refugee
10
Planetary Health
10
Ebola
7
Cholera
6
Polio
5
Conflict
5
Caregiver
5
Pharmacy
5
Zika
4
Disability
3
Natural Hazards
3
Mental Health
2
Global Health Education
2
Health Financing Toolbox
1
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with
...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo
...
first issued 18 August 2022
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera
...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t
...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first
...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach
...
